Enteric Disease Testing Industry

The global enteric disease testing market size was valued at USD 3.81 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030. Vital drivers of this market include technological advancements and supportive government funding in emerging economies. Furthermore, growing global demand for early diagnostics is expected to enhance the applicability of the market, fueling its growth.

Throughout the COVID-19 pandemic, there was an increasing focus on viral and bacterial infections, leading individuals to prioritize the consumption of home-cooked and hygienic food to minimize the risk of infection. Therefore, there was a decrease in the incidence of enteric diseases and a subsequent decline in the demand for enteric disease testing in 2020 and 2021. Additionally, COVID-19 testing had top priority during the pandemic, surpassing testing for other infectious diseases, due to which the demand for enteric disease testing products experienced a negative impact, thereby impeding market growth.

In regions such as Asia, Africa, and Latin America, the prevalence of enteric infections, including salmonella, campylobacter, escherichia coli, and norovirus, remains significantly high. According to the National Library of Medicine, as of 2018, a case fatality rate of 1% is observed in enteric fever cases in the Asia and Africa regions. Consequently, there is an increasing demand for enteric disease testing to enable accurate and timely diagnoses. Moreover, there is increasing awareness among individuals, healthcare providers, and government entities regarding the importance of early detection and effective management of enteric diseases. As a result, various organizations and government bodies are undertaking initiatives to enhance awareness, implement screening programs, and advocate for the utilization of diagnostic tests, thereby stimulating market growth.

Gather more insights about the market drivers, restrains and growth of the Global Enteric Disease Testing market

Enteric Disease Testing Market Segments:

Disease Type Insights

Based on disease type the market of enteric disease testing is segmented into bacterial, viral, and parasitic enteric diseases. The bacterial enteric diseases segment dominated the market with the largest revenue share and is also expected to grow at the fastest CAGR during the forecast period from 2023 to 2030. Various bacteria that cause these diseases include C. difficile, E. coli, shigella, salmonella, and campylobacter. According to the National Institute of Health, C. Difficile infections affect about half a million people in the U.S. every year. About 29,000 of these people die within a month of being diagnosed with the disease and E. Coli causes approximately 63,000 cases of hemorrhagic colitis in the U.S. every year.

Regional Insights

Europe dominated the market with the largest revenue share of 39.0% in 2022. Germany holds a considerable share in Europe’s market, primarily owing to its large geriatric population. According to the United Nation’s population data, one in every 20 people in Germany is aged above 80, which is expected to increase to one in every 6 individuals by 2050. People above the age of 65 accounted for 22.4% of the total population. In 2019, there were 90.4 million people above 65 years of age living in Europe. Problems with the increasing geriatric population include a higher risk of enteric diseases due to the onset of senescence & decreased immunity levels. Rapid diagnostic techniques such as point-of-care diagnostic devices are useful for this demographic. Key manufacturers such as Roche and Bio-Rad are strengthening their operations in Germany, which is expected to boost the enteric disease testing market.

Browse through Grand View Research's  Medical Devices Industry Research Reports.

  • The global molecular diagnostics market size was estimated at USD 15.20 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2030.
  • The global polymerase chain reaction market size was valued at USD 36.84 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of -9.30% from 2023 to 2030.

Key Companies & Market Share Insights

The players are involved in technological advancement and new product development in order to sustain their position in the market and offer cost-efficient solutions. For instance, in May 2022, BD announced the launch of a fully automated, ultra-high-throughput molecular diagnostic platform for infectious diseases in the U.S. Additionally, in February 2021, Thermo Fisher Scientific, Inc. announced the acquisition of Mesa Biotech, which aims to expand the benefits of molecular diagnostics at the point of care.

Furthermore, In January 2019, DiaSorin S.p.A. announced the launch of the FDA-approved Calprotectin test, LIAISON, for quantitative calprotectin assays in stool samples. This comes on the heels of the recent strategic partnership announced by DiaSorin S.p.A. with Meridian Bioscience to sell a stool antigen test. The following are some of the major participants in the global enteric disease testing market:

  • Abbott
  • BD
  • Biomerica
  • BIOMÉRIEUX
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Coris BioConcept
  • DiaSorin S.p.A.
  • Meridian Bioscience
  • Quest Diagnostics Incorporated

Segments Covered in the Report

Grand View Research has segmented the global enteric disease testing market on the basis of disease type, and region:

Enteric Disease Testing Disease Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Bacterial Enteric Disease
  • Viral Enteric Disease
    • Rotavirus
    • Norovirus
  • Parasitic Enteric Disease

Enteric Disease Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Order a free sample PDF of the Enteric Disease Testing Market Intelligence Study, published by Grand View Research.